[
  {
    "ts": "2025-10-07T17:45:00+00:00",
    "headline": "Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%",
    "summary": "AMGN rolls out AmgenNow, a direct-to-consumer program debuting with Repatha at a 60% lower price to boost patient access and affordability.",
    "url": "https://finance.yahoo.com/news/amgen-unveils-dtc-program-cuts-174500134.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b6e38834-4415-3b93-a388-f01c2c12fdeb",
      "content": {
        "id": "b6e38834-4415-3b93-a388-f01c2c12fdeb",
        "contentType": "STORY",
        "title": "Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%",
        "description": "",
        "summary": "AMGN rolls out AmgenNow, a direct-to-consumer program debuting with Repatha at a 60% lower price to boost patient access and affordability.",
        "pubDate": "2025-10-07T17:45:00Z",
        "displayTime": "2025-10-07T17:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cgmrsy.RXPZzY7yMaDwZPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HTl0ikZ844wasPEHHtWO1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-unveils-dtc-program-cuts-174500134.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-unveils-dtc-program-cuts-174500134.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-07T00:50:00+00:00",
    "headline": "/C O R R E C T I O N -- Amgen/",
    "summary": "Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha® (evolocumab). This follows landmark results demonstrating Repatha significantly reduced the risk of major adverse cardiovascular events (MACE) in individuals without a prior history of heart attack or stroke in the VESALIUS-CV Phase 3 trial.",
    "url": "https://finance.yahoo.com/news/amgen-makes-repatha-available-amgennow-130000839.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "a9e222ca-6252-328b-92d7-d8d9c3accb4c",
      "content": {
        "id": "a9e222ca-6252-328b-92d7-d8d9c3accb4c",
        "contentType": "STORY",
        "title": "/C O R R E C T I O N -- Amgen/",
        "description": "",
        "summary": "Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha® (evolocumab). This follows landmark results demonstrating Repatha significantly reduced the risk of major adverse cardiovascular events (MACE) in individuals without a prior history of heart attack or stroke in the VESALIUS-CV Phase 3 trial.",
        "pubDate": "2025-10-07T00:50:00Z",
        "displayTime": "2025-10-07T00:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d",
          "originalWidth": 400,
          "originalHeight": 98,
          "caption": "Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9xF64eSNrBTdXVSUBRIisA--~B/aD05ODt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d.cf.webp",
              "width": 400,
              "height": 98,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LmrL8PQB2Q2cD.YsureBSw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/dd88fc63427022d71ca8183432abc09d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-makes-repatha-available-amgennow-130000839.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-makes-repatha-available-amgennow-130000839.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]